Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $42.35 +3.82%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q4 EPS of $13.54. Revenue for the quarter came in at $69.8 million.
For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Popular stocks with increasing option volume: SPCX MU INTC AVGO MSTR PLTR SNDK NFLX ONDS
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
